Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60,549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Zhang JH, Zhang X, Zhou ZH, Zhu XJ, Zheng C, Li M, Jin SG, Mao DW, Xue JD, Shi WB, Chi XL, Wang XB, Li XD, Li Y, Wang H, Li Q, Zhou DQ, Wang CB, Shi CH, Li CZ, Wu JH, Kong XN, Sun XH, Gao YQ. Zhang JH, et al. Among authors: li y, li m, li cz, li q, li xd. Evid Based Complement Alternat Med. 2022 Mar 25;2022:6097221. doi: 10.1155/2022/6097221. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35368769 Free PMC article.
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled Trial.
Ye YA, Li XK, Zhou DQ, Chi XL, Li Q, Wang L, Lu BJ, Mao DW, Wu QK, Wang XB, Zhang MX, Xue JD, Li Y, Lu W, Guo JC, Jiang F, Zhang XW, Du HB, Yang XZ, Guo H, Gan DN, Li ZG. Ye YA, et al. Among authors: li zg, li xk, li y, li q. Chin J Integr Med. 2018 Sep;24(9):653-660. doi: 10.1007/s11655-018-3011-5. Epub 2018 Sep 12. Chin J Integr Med. 2018. PMID: 30209792
A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Chen Y, Wang Y, Chen Y, Yu Z, Chi X, Hu KQ, Li Q, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chi W, Dong Z, Wang X, Li Z, Xiao H, Chen D, Bai W, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Sun H, Deng M, Qi X, Zhang Z, Qi X, Yang Y. Chen Y, et al. Among authors: li z, li q. Clin Transl Gastroenterol. 2019 May 22;10(5):1-12. doi: 10.14309/ctg.0000000000000033. Clin Transl Gastroenterol. 2019. PMID: 31033506 Free PMC article.
On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
Chang XJ, Sun C, Chen Y, Li XD, Yu ZJ, Dong Z, Bai WL, Wang XD, Li ZQ, Chen D, Du WJ, Liao H, Jiang QY, Sun LJ, Li YY, Zhang CH, Xu DP, Chen YP, Li Q, Yang YP. Chang XJ, et al. Among authors: li yy, li zq, li q, li xd. World J Gastroenterol. 2019 Aug 28;25(32):4764-4778. doi: 10.3748/wjg.v25.i32.4764. World J Gastroenterol. 2019. PMID: 31528100 Free PMC article. Clinical Trial.
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Rong G, Chen Y, Yu Z, Li Q, Bi J, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chen Y, Dong Z, Bai W, Yoshida EM, Mendez-Sanchez N, Hu KQ, Qi X, Yang Y. Rong G, et al. Among authors: li q. J Infect Dis. 2022 Mar 15;225(6):1091-1099. doi: 10.1093/infdis/jiaa266. J Infect Dis. 2022. PMID: 32437567 Free PMC article. Clinical Trial.
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial.
Li X, Zhou D, Chi X, Li Q, Wang L, Lu B, Mao D, Wu Q, Wang X, Zhang M, Xue J, Li Y, Lu W, Guo J, Jiang F, Zhang X, Li Z, Yang X, Guo H, Gan D, He L, Luo L, Zhang L, Du H, Ye Y. Li X, et al. Among authors: li y, li z, li q. Hepatol Int. 2020 Dec;14(6):985-996. doi: 10.1007/s12072-020-10097-z. Epub 2020 Oct 30. Hepatol Int. 2020. PMID: 33128206 Clinical Trial.
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
Xiao HM, Shi MJ, Jiang JM, Cai GS, Xie YB, Tian GJ, Xue JD, Mao DW, Li Q, Yang HZ, Guo H, Lei CL, Lu W, Chen L, Liu HB, Wang J, Gao YQ, Chen JZ, Wu SD, Chen HJ, Zhao PT, Zhang CZ, Ou-Yang WW, Wen ZH, Chi XL. Xiao HM, et al. Among authors: li q. J Ethnopharmacol. 2022 Jul 15;293:115210. doi: 10.1016/j.jep.2022.115210. Epub 2022 Apr 7. J Ethnopharmacol. 2022. PMID: 35398501 Free article. Clinical Trial.
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
Ji D, Chen Y, Shang Q, Liu H, Tan L, Wang J, Chen Y, Li Q, Long Q, Song L, Jiang L, Xiao G, Yu Z, Chen L, Hu X, Wang X, Chen D, Li Z, Dong Z, Chen G, Yang Y. Ji D, et al. Among authors: li z, li q. Am J Gastroenterol. 2021 Aug 1;116(8):1676-1685. doi: 10.14309/ajg.0000000000001239. Am J Gastroenterol. 2021. PMID: 33840727 Free PMC article.
A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection.
Chang X, Wang J, Chen Y, Long Q, Song L, Li Q, Liu H, Shang Q, Yu Z, Jiang L, Xiao G, Li L, Chen L, Wang X, Li Z, Chen D, Dong Z, An L, Tan L, Chen Y, Yang Y. Chang X, et al. Among authors: li z, li l, li q. EBioMedicine. 2021 May;67:103389. doi: 10.1016/j.ebiom.2021.103389. Epub 2021 May 17. EBioMedicine. 2021. PMID: 34004423 Free PMC article.
Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment.
Chang XJ, Shi YW, Wang J, Liu HB, Chen Y, Zhu XN, Chen YP, Yu ZJ, Shang QH, Tan L, Li Q, Jiang L, Xiao GM, Chen L, Lu W, Hu XY, Long QH, An LJ, Zou ZY, Wong VW, Yang YP, Fan JG. Chang XJ, et al. Among authors: li q. Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):416-425. doi: 10.1016/j.hbpd.2021.06.009. Epub 2021 Jul 7. Hepatobiliary Pancreat Dis Int. 2021. PMID: 34275749
60,549 results
You have reached the last available page of results. Please see the User Guide for more information.